Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-incisional Infiltration With Ropivacaine Plus Triamcinolone in VATS
NCT07603921Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2026
- Primary completion
- May 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of triamcinolone in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Intravenous Morphine Equivalents of Rescue Analgesic Medications at 48 hours. Started Sep 2026; status: recruiting.
02
Drugs
triamcinolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07603921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07603921.